Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (8)

« Back to Publications

PHACTR1 modulates vascular compliance but not endothelial function: a translational study.

Wood A. et al, (2023), Cardiovasc Res, 119, 599 - 610

Tamoxifen exacerbates morbidity and mortality in male mice receiving medetomidine anaesthesia.

Rashbrook VS. et al, (2023), Anim Welf, 32

Cre toxicity in mouse models of cardiovascular physiology and disease.

Rashbrook VS. et al, (2022), Nat Cardiovasc Res, 1, 806 - 816

A key role for the novel coronary artery disease gene JCAD in atherosclerosis via shear stress mechanotransduction.

Douglas G. et al, (2020), Cardiovasc Res, 116, 1863 - 1874

Tamoxifen-Activated CreERT Impairs Retinal Angiogenesis Independently of Gene Deletion.

Brash JT. et al, (2020), Circ Res, 127, 849 - 850

Roles for endothelial cell and macrophage Gch1 and tetrahydrobiopterin in atherosclerosis progression.

Douglas G. et al, (2018), Cardiovasc Res, 114, 1385 - 1399

Endothelial Cell Tetrahydrobiopterin Modulates Sensitivity to Ang (Angiotensin) II-Induced Vascular Remodeling, Blood Pressure, and Abdominal Aortic Aneurysm.

Chuaiphichai S. et al, (2018), Hypertension, 72, 128 - 138

Human venous valve disease caused by mutations in FOXC2 and GJC2.

Lyons O. et al, (2017), J Exp Med, 214, 2437 - 2452